Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 46 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Karagiannis, Thomas  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Bekiari, E., Karagiannis T., Haidich A-B., & Tsapas A. (2017).  Meta-analysis of artificial pancreas trials: methodological considerations. The Lancet Diabetes & Endocrinology. 5(9), 685.
Bekiari, E., Karagiannis T., Haidich A-B., & Tsapas A. (2017).  Meta-analysis of artificial pancreas trials: methodological considerations.. Lancet Diabetes Endocrinol. 5(9), 685.
Karagiannis, T., Tsapas A., Bekiari E., Toulis K. A., & Nauck M. A. (2024).  A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes.. Diabetes Care. 47(2), 184-192.
Karagiannis, T., & Bekiari E. (2016).  Most add-on therapies to metformin have similar effects on HbA1c.. Evid Based Med. 21(6), 223.
O
Stoimenis, D., Karagiannis T., Katsoula A., Athanasiadou E., Kazakos K., Bekiari E., et al. (2017).  Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis. Expert Opinion on Pharmacotherapy. 18555857646565(9111111), 843 - 851.
Stoimenis, D., Karagiannis T., Katsoula A., Athanasiadou E., Kazakos K., Bekiari E., et al. (2017).  Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis.. Expert Opin Pharmacother. 18(9), 843-851.
P
Tsapas, A., Karagiannis T., & Bekiari E. (2016).  Premixed insulin regimens for type 2 diabetes. Endocrine. 5128136293852682932172681092030295868(321Suppl 2811036512641555321), 387 - 389.
Kostopoulos, G., Doundoulakis I., Toulis K. A., Karagiannis T., Tsapas A., & Haidich A-B. (2023).  Prognostic models for heart failure in patients with type 2 diabetes: a systematic review and meta-analysis.. Heart.
R
Avgerinos, I., Karagiannis T., Liakos A., Tsapas A., & Bekiari E. (2023).  Racial, ethnic and sex disparities among participants in cardiovascular outcomes trials in type 2 diabetes: A systematic review and descriptive analysis.. Diabetes Obes Metab. 25(2), 618-622.
S
Karagiannis, T., Boura P., & Tsapas A. (2014).  Safety of dipeptidyl peptidase 4 inhibitors: a perspective review.. Ther Adv Drug Saf. 5(3), 138-46.
Andreadis, P., Karagiannis T., Malandris K., Avgerinos I., Liakos A., Manolopoulos A., et al. (2018).  Semaglutide for type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes, Obesity and Metabolism.
Andreadis, P., Karagiannis T., Malandris K., Avgerinos I., Liakos A., Manolopoulos A., et al. (2018).  Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis.. Diabetes Obes Metab. 20(9), 2255-2263.
Tsapas, A., Liakos A., Paschos P., Karagiannis T., Bekiari E., Tentolouris N., et al. (2014).  A simple plaster for screening for diabetic neuropathy: a diagnostic test accuracy systematic review and meta-analysis.. Metabolism. 63(4), 584-92.
Karagiannis, T., Bekiari E., & Tsapas A. (2023).  Socioeconomic aspects of incretin-based therapy.. Diabetologia. 66(10), 1859-1868.
Vasilakou, D., Karagiannis T., Athanasiadou E., Mainou M., Liakos A., Bekiari E., et al. (2013).  Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.. Ann Intern Med. 159(4), 262-74.
Avgerinos, I., Karagiannis T., Kakotrichi P., Michailidis T., Liakos A., Matthews D. R., et al. (2022).  Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis.. Diabetes Obes Metab. 24(1), 106-114.
Bekiari, E., Rizava C., Athanasiadou E., Papatheodorou K., Liakos A., Karagiannis T., et al. (2016).  Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes. Endocrine. 458 - 480.
U
Avgerinos, I., Papanastasiou G., Karagiannis T., Michailidis T., Liakos A., Mainou M., et al. (2021).  Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis.. Diabetes Obes Metab. 23(10), 2395-2401.
Liakos, A., Karagiannis T., Bekiari E., Boura P., & Tsapas A. (2015).  Update on long-term efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus.. Ther Adv Endocrinol Metab. 6(2), 61-7.
Karagiannis, T., Liakos A., Branda M. E., Athanasiadou E., Mainou M., Boura P., et al. (2016).  Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial. BMJ Open. 6(11), e012185.
Karagiannis, T., Liakos A., Branda M. E., Athanasiadou E., Mainou M., Boura P., et al. (2016).  Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial.. BMJ Open. 6(11), e012185.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές